AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Eveglim-M 0.5 Tablet ER

Prescription Icon
Prescription Required

Marketer

Eleveton Pharma

Salt Composition

Glimepiride (0.5mg) + Metformin (500mg)

Overview Eveglim-M 0.5 Tablet ER

Diabex Duo 0.5mg Extended-Release tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer Diabex Duo 0.5mg ER with food, consistently at the same time daily for optimal efficacy. Dosage is determined individually by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to complications such as nephropathy, retinopathy, neuropathy, and peripheral vascular disease. This medication forms part of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are essential for effective diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, vertigo, cephalgia, and tremor. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are vital. Alcohol consumption should be minimized due to its hypoglycemic potential. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur in some patients. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before commencing treatment. Consult your doctor prior to use during pregnancy or breastfeeding. Regular blood glucose monitoring and periodic blood tests (complete blood count, liver function tests) are recommended.

Primary Ingredients of Eveglim-M 0.5 Tablet ER

No text provided. Please provide the text you wish me to rewrite.

Uses of Eveglim-M 0.5 Tablet ER

Managing Type 2 Diabetes

Major Benefits of Eveglim-M 0.5 Tablet ER:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take Eveglim-M 0.5mg Extended-Release Tablet with food.

Common Side effects of Eveglim-M 0.5 Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Eveglim-M 0.5 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; avoid crushing, chewing, or breaking it. Consume Eveglim-M 0.5 mg Extended-Release tablet with food.

How Eveglim-M 0.5 Tablet ER works:

Eveglim-M 0.5 Extended-Release tablets contain a dual-action antidiabetic formulation: glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Eveglim-M 0.5 Tablet ER and alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Eveglim-M 0.5mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against potential hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Eveglim-M 0.5mg tablets are contraindicated for breastfeeding mothers due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Eveglim-M 0.5 Tablet ER cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Consult a physician. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Eveglim-M 0.5 Tablet ER cautiously, potentially requiring dosage modification. Consult a physician for guidance. In those with mild to moderate hepatic dysfunction, initiation at a reduced dose is typical; however, its use is contraindicated in patients with severe liver disease.

What if you forget to take Eveglim-M 0.5 Tablet ER :

Should you forget to take a dose of Eveglim-M 0.5 Tablet ER, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Eveglim-M 0.5 Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Eveglim-M 0.5 Tablet ER

Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication. Keep it out of reach of children, pets, and others.
Eveglim-M 0.5 Tablet ER can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Eveglim-M 0.5 Tablet ER and seek immediate medical attention.
Eveglim-M 0.5 Tablet ER combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication enhances blood glucose control when coupled with a healthy diet and regular physical activity. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. It's not suitable for type 1 DM.
Eveglim-M 0.5 Tablet ER may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Prolonged Eveglim-M 0.5 Tablet ER use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, supplemental vitamin B12 is recommended annually by some researchers.
Eveglim-M 0.5 Tablet ER can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Eveglim-M 0.5 Tablet ER and alcohol is unsafe. Alcohol can exacerbate the drug's blood sugar-lowering effect, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Eveglim-M 0.5 Tablet ER
26
MRP 32
18% off